What is Solve Therapeutics worth?
$439.0Mlast known valuation
Solve Therapeutics last raised $48.2M in its Early Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Solve Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $48.2M | ▮ | ▮ |
| Dec 2024 | Later Stage VC | $50.4M | ▮ | ▮ |
| Dec 2021 | Later Stage VC | $63.5M | ▮ | ▮ |
How Solve Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Solve Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Solve Therapeutics worth?
- Solve Therapeutics's last known valuation is $439.0M.
- How much has Solve Therapeutics raised?
- Solve Therapeutics has raised $384.5M in total funding across 3 recorded rounds.
- When did Solve Therapeutics last raise?
- Solve Therapeutics last raised in Nov 2025 (Early Stage VC), raising $48.2M.